The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly
differentiated new medicines to improve human health.
Website:www.mrlv.com
Industries:
Biotechnology
Genetics
Life Science
Therapeutics
Medical
Product Research
Health Care
Emergency Medicine
Health Diagnostics
Investor Types:
Venture Capital
Investment Stages:
Seed
Early Stage Venture
Location:
Cambridge, Massachusetts, United States
